Darcy L. DiFede

Advancing the Field of Regenerative Medicine

Darcy L. DiFede, 2013 .

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

Robert C. Hendel, Darcy L. DiFede, Joshua M. Hare, 2017, Circulation research.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Darcy L. DiFede, Peter A. Altman, R. Hendel, 2014, JAMA.

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy

Darcy L. DiFede, R. Myerburg, A. Heldman, 2019, EBioMedicine.